Get 5% off or get the better offer price when you opt-in for recurring deliveries with Auto-Reorder. Available on UK deliveries only.
Learn moreGet 5% off or get the better offer price on this and 1000s more items when you opt-in for recurring deliveries with Auto-Reorder. Your discount is applied from your first recurring delivery.
Shop 1000s of everyday essentials and get them delivered automatically with Auto-Reorder.
Decide how frequently you want your top-ups delivered and we'll do the rest.
With each regular delivery you'll get either 5% off or get our better offer price
100% commitment free, no contracts or paperwork to fill in and you can cancel at any time for complete peace of mind.
Shop other sizes and multipacks
Please note images are for illustration purposes and may differ from the product(s) you receive
Relieve the symptoms of hay fever and allergies with a one-a-day tablet.
Piriteze One A Day Tablets are used to treat the symptoms of hayfever (itchy or watery eyes, sneezing and a runny nose) and other allergies e.g. pet, house dust mite and mould spore allergies. They can also be used to relieve the rashes and itching of hives.
Please read the enclosed leaflet carefully before use.
Do not exceed the stated dose.
Warning. May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink.
If symptoms persist, or if you are pregnant or breast-feeding, consult your doctor.
Keep out of the sight and reach of children.
Possible side effects whilst taking Piriteze Tablets:
Most people taking these tablets find the cause them no problems. Occasionally some people may have:
These are all temporary, mild side effects of this medicine. Very rarely, these tablets may cause convulsions. If this happens to you, stop taking these tablets and tell your doctor. If you notice any side effects not mentioned in the leaflet, please inform your doctor or pharmacist.
Each tablet contains the active ingredients Cetirizine Hydrochloride 10 mg. Also includes Lactose - see leaflet for further advice.
